Old Web
English
Sign In
Acemap
>
authorDetail
>
H. Patel
H. Patel
Genentech
Atezolizumab
Oncology
Medicine
Internal medicine
Pathology
5
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
IMpower110: Clinical safety in a phase III study of atezolizumab (atezo) monotherapy (mono) vs platinum-based chemotherapy (chemo) in first-line non-small cell lung cancer (NSCLC).
2020
Journal of Clinical Oncology
Jacek Jassem
Roy S. Herbst
Filippo De Marinis
Jacques Cadranel
Tibor Csőszi
Dolores Isla
Gongyan Chen
Konstantinos N. Syrigos
Diego Cortinovis
Toyoaki Hida
Simonetta Mocci
See Phan
Ida Berglin Enquist
H. Patel
Monette Villalobos
Xiaohui Wen
Yu Deng
Hiroshi Kuriki
David R. Spigel
Giuseppe Giaccone
Show All
Source
Cite
Save
Citations (5)
Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer.
2020
Journal of Clinical Oncology
Martin Reck
Thomas Wehler
Francisco Jorquera Orlandi
Naoyuki Nogami
Carlo Barone
Denis Moro-Sibilot
Mikhail Shtivelband
Jose-Luis Gonzalez-Larriba
Jeffrey Rothenstein
Martin Früh
Wei Yu
Yu Deng
Shelley Coleman
G. Shankar
H. Patel
Claudia Kelsch
Anthony Lee
Elisabeth Piault
Mark A. Socinski
Show All
Source
Cite
Save
Citations (14)
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
2019
Cancer Chemotherapy and Pharmacology
Kari M. Morrissey
Mathilde Marchand
H. Patel
Rong Zhang
Benjamin Wu
H. Phyllis Chan
Almut Mecke
Sandhya Girish
Jin Y. Jin
Helen Winter
Rene Bruno
Show All
Source
Cite
Save
Citations (29)
1